M Bio Technology Inc. develops innovative vaccine, diagnostics, precision therapy for Mycoplasma Infectious Diseases (MID). The pathogenesis of Mycoplasma Infectious Diseases (MID) is systemic vasculitis/neuritis, which had been made it confusingly difficult to diagnose and treat (MID SpectrumTM). M Bio Thechnology is a leading company focused on the discovery and development of innovative therapeutic strategy, vaccine, diagnostics, precision therapy for MID. We have succssfully made brackthrough to establish innovative diagnostics (MID PrismTM). The MID related patents have been registered in Japan, US, Australia etc. We would like to explore mutual business opportunities, in the field of diagnostics, therapeutics (MID MedicineTM, MID AntibodiesTM) including vaccines (MID VaccinesTM) based on the platform technology (MID Platform TM). M Bio Technology Inc. is seeking for partnering opportunities to create global network for the advanced precision medicine.